BIPROGY (8056) Q2 2025 earnings summary

Executive summary

• H1 FYMar2025 revenue rose 7.5% YoY to ¥186,032 million, driven by DX demand and growth in outsourcing and product sales.

• Operating profit increased 7.9% to ¥17,945 million; adjusted operating profit rose 4.6% to ¥17,294 million.

• Profit attributable to owners of parent fell 8.2% to ¥11,769 million, reflecting fund valuation losses, exchange-rate effects and higher income taxes.

• Orders and backlogs grew across the business; full-year performance guidance was unchanged.

• Management Policies (2024–2026) target a sustainable business portfolio and stronger management base.

Financial highlights

• Gross profit increased to ¥48,698 million from ¥46,197 million; SG&A rose ¥1.7 billion to ¥31.4 billion, including higher internal-system and personnel costs.

• Total assets were ¥291,443 million at September 30, 2024, down ¥22,775 million from March 31, mainly due to lower cash and cash equivalents.

• Period-end cash and cash equivalents were ¥41,291 million, down ¥17,971 million from the previous fiscal year-end.

• Operating cash flow was ¥11,768 million; investing and financing cash flows were net outflows of ¥7,076 million and ¥22,830 million, respectively.

• Equity attributable to owners of parent was ¥159,981 million; owners' equity to gross assets ratio was 54.9%.

Outlook and guidance

• FYMar2025 forecast unchanged: revenue ¥385,000 million (+4.0%), operating profit and profit before tax ¥35,500 million, and profit attributable to owners of parent ¥24,500 million (-3.0%).

• Full-year adjusted operating profit forecast is ¥35.0 billion (+3.5%); operating margin forecast is 9.2%, versus 9.0% in FYMar2024.

• FYMar2025 basic EPS is forecast at ¥243.72.

• Growth-business focus-area revenue target is ¥13.5 billion, up 42.7% from FYMar2024 results of ¥9.5 billion.